Skip to Content
You are currently on the new version of our website. Access the old version .
MetabolitesMetabolites
  • Article
  • Open Access

17 March 2022

12 Pages

High Resolution Magic Angle Spinning Proton NMR Study of Alzheimer’s Disease with Mouse Models

,
,
,
,
,
,
,
,
and
1
Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02115, USA
2
Hopp Children’s Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany
3
Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
4
Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02115, USA

Abstract

Alzheimer’s disease (AD) is a crippling condition that affects millions of elderly adults each year, yet there remains a serious need for improved methods of diagnosis. Metabolomic analysis has been proposed as a potential methodology to better investigate and understand the progression of this disease; however, studies of human brain tissue metabolomics are challenging, due to sample limitations and ethical considerations. Comprehensive comparisons of imaging measurements in animal models to identify similarities and differences between aging- and AD-associated metabolic changes should thus be tested and validated for future human non-invasive studies. In this paper, we present the results of our highresolution magic angle spinning (HRMAS) nuclear magnetic resonance (NMR) studies of AD and wild-type (WT) mouse models, based on animal age, brain regions, including cortex vs. hippocampus, and disease status. Our findings suggest the ability of HRMAS NMR to differentiate between AD and WT mice using brain metabolomics, which potentially can be implemented in in vivo evaluations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.